The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF
Part of paid clinical trials in Las Vegas, Nevada.
- Sponsor
- Ovation Fertility
- Study ID
- NCT06521372
- Status
- Recruiting
Conditions
- Infertility Primary
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Magenta AI image analysis tool — OTHERMagentaTM is a non-invasive image analysis tool that utilizes artificial intelligence to evaluate 2-dimensional images of denuded mature MII oocytes. The MagentaTM software has been analyzed retrospectively, by Future Fertility. This data displays that a higher MagentaTM score is associated with a higher chance of blastocyst development. Additionally, the MagentaTM software has been validated in a prospective multi-center study, displaying that a higher MagentaTM score correlates to a higher chance of blastocyst development.
Study Details
The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.
Key Dates
- Start date
- Jan 1, 2024
- Status verified
- Jul 2024
- Primary completion
- Jan 1, 2026
- Completion
- Jan 2, 2027
Study Design
- Enrollment
- 450 participants (estimated)
Arms
- Arm: Oocytes with AIOocytes assessed by the Magenta software
- Arm: Oocytes without AIOocytes randomly selected
Primary Outcome Measure
Compare blastocyst development rate [ Time Frame: 5 to 7 days ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ovation Fertility Las Vegas | Las Vegas | Nevada | 89113 | Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR) |
| Ovation Fertility Cincinnati | Cincinnati | Ohio | 45209 | Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR) |
| Ovation Fertility - Nashville | Nashville | Tennessee | 37203 | Matthew VerMilyea, PhD (PRINCIPAL_INVESTIGATOR) |